Evaluation of liver function using liver parenchyma, spleen and portal vein signal intensities during the hepatobiliary phase in Gd-EOB-D TPA-enhanced MRI

Background Previous studies have used signal intensity (SI) to reflect liver function. However, few studies have evaluated liver function via the portal vein. Regarding the SI of the liver, spleen, and portal vein, no study has indicated which can best reflect liver function. Therefore, the aim of this study is to investigate whether these parameters can evaluate liver function in patients with cirrhosis and determine which is the best parameter. Methods 120 patients with normal livers (n = 41) or Child–Pugh class A (n = 50), B (n = 21) or C (n = 8) disease who had undergone Gd-EOB-DTPA-enhanced MRI were retrospectively reviewed. Comparisons of the MRI data (liver parenchyma SI, portal vein SI, and spleen SI and liver-to-portal vein contrast ratio (LPC), liver-to-spleen contrast ratio (LSC), and portal vein-to-spleen contrast ratio (PSC)) in the 15-min hepatobiliary phase images were performed among the groups, and the correlations among the liver function parameters (total bilirubin, direct bilirubin, indirect bilirubin, aspartate aminotransferase, alanine aminotransferase, albumin, creatinine, platelet count, prothrombin time and international normalized ratio), liver function scores and MRI data were also quantitatively analysed. Results Significant differences were observed in the liver parenchyma SI, LPC and LSC among the groups. These values all decreased gradually from normal livers to Child–Pugh class C cirrhotic livers ( P  < 0.001). The portal vein SI constantly and slightly increased from normal livers to Child–Pugh class C cirrhotic livers, but no differences were found among the groups in the portal vein SI and PSC ( P  > 0.05). LPC showed a stronger correlation with the Child–Pugh score and MELD score than LSC and the liver parenchyma SI. The order of the AUCs of these parameters, from largest to smallest, was as follows: LPC, LSC, and liver parenchyma SI ( P  > 0.05). Conclusion The liver parenchyma SI, LSC and LPC may be used as alternative imaging biomarkers to assess liver function, while the portal vein SI and PSC do not reflect liver function. Furthermore, LPC values can more effectively distinguish severity among patients with cirrhosis than the liver parenchyma SI and LSC.

[1]  S. Kumano,et al.  Estimation of liver function using T2* mapping on gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid enhanced magnetic resonance imaging. , 2012, European journal of radiology.

[2]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[3]  L. V. van Vliet,et al.  Comparison between dynamic gadoxetate-enhanced MRI and 99mTc-mebrofenin hepatobiliary scintigraphy with SPECT for quantitative assessment of liver function , 2019, European Radiology.

[4]  T. Sone,et al.  Gd-EOB-DTPA enhanced MR imaging: evaluation of biliary and renal excretion in normal and cirrhotic livers. , 2011, European journal of radiology.

[5]  U. Motosugi,et al.  Liver parenchymal enhancement of hepatocyte‐phase images in Gd‐EOB‐DTPA‐enhanced MR imaging: Which biological markers of the liver function affect the enhancement? , 2009, Journal of magnetic resonance imaging : JMRI.

[6]  T. Miyati,et al.  A novel method for evaluating enhancement using gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid in the hepatobiliary phase of magnetic resonance imaging. , 2016, Clinical imaging.

[7]  P. Meier,et al.  Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1. , 1999, The Journal of pharmacology and experimental therapeutics.

[8]  T. Nakayama,et al.  Liver analysis using gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid‐enhanced magnetic resonance imaging: Correlation with histological grading and quantitative liver evaluation prior to hepatectomy , 2012, Hepatology research : the official journal of the Japan Society of Hepatology.

[9]  J. Ledsam,et al.  Measuring hepatic functional reserve using low temporal resolution Gd-EOB-DTPA dynamic contrast-enhanced MRI: a preliminary study comparing galactosyl human serum albumin scintigraphy with indocyanine green retention , 2013, European Radiology.

[10]  S. Kumano,et al.  Estimation of Liver Function Using T1 Mapping on Gd-EOB-DTPA-Enhanced Magnetic Resonance Imaging , 2011, Investigative radiology.

[11]  A. Teufel,et al.  Liver fibrosis and Gd-EOB-DTPA-enhanced MRI: A histopathologic correlation , 2015, Scientific Reports.

[12]  T. Frenzel,et al.  Mechanism of hepatic uptake of gadoxetate disodium. , 1996, Academic radiology.

[13]  F. Wacker,et al.  Functional gadoxetate disodium-enhanced MRI in patients with primary sclerosing cholangitis (PSC) , 2016, European Radiology.

[14]  J. Kao,et al.  Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients , 2011, European Radiology.

[15]  D. Seehofer,et al.  Imaging-based evaluation of liver function: comparison of 99mTc-mebrofenin hepatobiliary scintigraphy and Gd-EOB-DTPA-enhanced MRI , 2015, European Radiology.

[16]  T. Nagao,et al.  Diagnostic efficacy of gadoxetic acid-enhanced MRI for hepatocellular carcinoma and dysplastic nodule. , 2011, World journal of gastroenterology.

[17]  J. Lodge Assessment of hepatic reserve for the indication of hepatic resection: how I do it. , 2005, Journal of hepato-biliary-pancreatic surgery.

[18]  H. Weinmann,et al.  Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. , 1992, Radiology.

[19]  V. Chernyak,et al.  Improved parenchymal liver enhancement with extended delay on Gd-EOB-DTPA-enhanced MRI in patients with parenchymal liver disease: associated clinical and imaging factors. , 2015, Clinical radiology.

[20]  O. Matsui,et al.  Relationship between signal intensity on hepatobiliary phase of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced MR imaging and prognosis of borderline lesions of hepatocellular carcinoma. , 2012, European journal of radiology.

[21]  K. Bae,et al.  Biliary tract enhancement in gadoxetic acid-enhanced MRI correlates with liver function biomarkers. , 2016, European journal of radiology.

[22]  坪山 尚寛 Hepatocellular carcinoma : hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging : correlation with expression of sinusoidal and canalicular transporters and bile accumulation , 2012 .

[23]  T. Utsunomiya,et al.  Possible utility of MRI using Gd-EOB-DTPA for estimating liver functional reserve , 2012, Journal of Gastroenterology.

[24]  H. Hussain,et al.  Primovist, Eovist: what to expect? , 2012, Journal of hepatology.

[25]  Po-Huang Lee,et al.  Use of indocyanine green for functional assessment of human hepatocytes for transplantation. , 2012, Asian journal of surgery.

[26]  B. Hamm,et al.  Imaging-Based Liver Function Tests – Past, Present and Future , 2015, Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.

[27]  Tae Un Kim,et al.  Significance of the “Delayed hyperintense portal vein sign” in the hepatobiliary phase MRI obtained with Gd‐EOB‐DTPA , 2012, Journal of magnetic resonance imaging : JMRI.

[28]  T. Tamada,et al.  Hepatic parenchymal enhancement at Gd-EOB-DTPA-enhanced MR imaging: correlation with morphological grading of severity in cirrhosis and chronic hepatitis. , 2012, Magnetic resonance imaging.

[29]  M. Filauro,et al.  Assessment of hepatic reserve for the indication of hepatic resection: how I do it. , 2005, Journal of hepato-biliary-pancreatic surgery.

[30]  P. Sandström,et al.  Quantifying differences in hepatic uptake of the liver specific contrast agents Gd-EOB-DTPA and Gd-BOPTA: a pilot study , 2012, European Radiology.

[31]  J. Han,et al.  Quantitative Liver Function Analysis: Volumetric T1 Mapping with Fast Multisection B1 Inhomogeneity Correction in Hepatocyte-specific Contrast-enhanced Liver MR Imaging. , 2017, Radiology.

[32]  J. Veniero,et al.  Focal liver lesion detection and characterization with GD-EOB-DTPA. , 2011, Clinical radiology.

[33]  Chunhong Hu,et al.  Liver function correlates with liver-to-portal vein contrast ratio during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MR at 3 Tesla , 2018, Abdominal Radiology.

[34]  E. Gabazza,et al.  Recent advances in bilirubin metabolism research: the molecular mechanism of hepatocyte bilirubin transport and its clinical relevance , 2000, Journal of Gastroenterology.